Please assess the completion status of the following clinical trial:

Trial Title: Explorations of the Benefits of the ZeroG TRiP System to Improve Balance in Patients Following Stroke

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Admission Berg Balance Scale score of 21 or greater~* 18 years of age or older~* Be able to understand and respond to simple verbal instructions in any language~* Be able to physically tolerate and actively participate in at least three, 30 minute weekly sessions in the ZeroG body weight support system~Exclusion Criteria:~* Cognitive deficits that would disrupt the ability to provide informed consent~* Admission Berg Balance Scale score less than 21~* Uncontrolled hypotension~* Uncontrolled hypertension~* Unstable skin structure (i.e. skin grafts, chest tubes)~* Unstable rib or lower extremity fractures~* Osteoporosis~* Active enteric infection control precautions~* New limb amputations~* Need for greater than 50% high flow oxygen~* Body weight greater than 450 pounds (structural limitations of the ZeroG body weight support system)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Body weight support system control group (Type: ACTIVE_COMPARATOR): In this arm, participants will undergo their normal physical therapy treatment while using the ZeroG body weight support system.
- Body weight support system with balance perturbations (Type: EXPERIMENTAL): Similar to the control group arm, participants will undergo their normal physical therapy treatment while using the ZeroG body weight support system, with the inclusion of 8 total balance perturbations each session, including 2 in the posterior, anterior, left lateral, and right lateral directions.
- Historical Standard of Care control (Type: NO_INTERVENTION): Retrospective anonymized Berg Balance Score data of stroke inpatients was collected from an institutional report for fiscal year 2018. 2018 was chosen as it preceded the implementation of the ZeroG body weight support system and reflects a no-intervention control baseline. This data was then filtered to show only patients with a Berg score of 21 or greater to match the study's inclusion criteria.

Based on this trial design, predict the completion outcome and termination type (if applicable).